Knightsbridge Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $903K | Buy |
7,140
+450
| +7% | +$56.9K | 0.2% | 65 |
|
|
2025
Q1 | $856K | Sell |
6,690
-1,335
| -17% | -$171K | 0.22% | 63 |
|
|
2024
Q4 | $1.06M | Sell |
8,025
-72
| -0.9% | -$9.52K | 0.25% | 59 |
|
|
2024
Q3 | $1.18M | Hold |
8,097
| – | – | 0.26% | 58 |
|
|
2024
Q2 | $1.11M | Sell |
8,097
-93
| -1% | -$12.8K | 0.28% | 58 |
|
|
2024
Q1 | $1.11M | Hold |
8,190
| – | – | 0.31% | 57 |
|
|
2023
Q4 | $1.11M | Sell |
8,190
-510
| -6% | -$69.3K | 0.31% | 57 |
|
|
2023
Q3 | $1.06M | Hold |
8,700
| – | – | 0.34% | 57 |
|
|
2023
Q2 | $1.11M | Sell |
8,700
-8,700
| -50% | -$1.11M | 0.36% | 56 |
|
|
2023
Q1 | $2.25M | Hold |
17,400
| – | – | 0.38% | 55 |
|
|
2022
Q4 | $2.28M | Hold |
17,400
| – | – | 0.43% | 55 |
|
|
2022
Q3 | $2.04M | Hold |
17,400
| – | – | 0.43% | 50 |
|
|
2022
Q2 | $2.05M | Buy |
17,400
+7,750
| +80% | +$912K | 0.41% | 50 |
|
|
2022
Q1 | $1.26M | Hold |
9,650
| – | – | 0.42% | 52 |
|
|
2021
Q4 | $1.47M | Hold |
9,650
| – | – | 0.49% | 50 |
|
|
2021
Q3 | $1.56M | Sell |
9,650
-700
| -7% | -$113K | 0.55% | 45 |
|
|
2021
Q2 | $1.69M | Hold |
10,350
| – | – | 0.66% | 35 |
|
|
2021
Q1 | $1.56M | Hold |
10,350
| – | – | 0.66% | 33 |
|
|
2020
Q4 | $1.57M | Hold |
10,350
| – | – | 0.77% | 29 |
|
|
2020
Q3 | $1.4M | Hold |
10,350
| – | – | 0.81% | 29 |
|
|
2020
Q2 | $1.42M | Buy |
+10,350
| New | +$1.42M | 0.92% | 26 |
|